| 摘要 |
The subject matter of the present invention is a method for the diagnosis or prognosis, in vitro, of testicular cancer, which comprises a step of detecting at least one expression product of at least one HERV nucleic acid sequence, the use of said nucleic acid sequences, which have been isolated, as a molecular marker or molecular markers, and a kit comprising at least one binding partner specific for at least one of the expression products of the HERV nucleic acid sequences. |
